Novel syringe closure system honored for its innovative design and enhanced user experience
· Award recognizes innovative design concept
· New syringe closure system builds on more than two decades of market success
Ravensburg, October 15, 2026: Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), has received a Red Dot Award in the category "Design Concept" for its next-generation syringe closure system, V-OVS® next. The internationally recognized award honors forward-looking product concepts distinguished by innovation, functionality, and design excellence. The recognition highlights Vetter's continued commitment to developing an advanced closure system that improves the user experience while supporting the evolving needs of pharma and biotech companies.
Developed in response to
growing market complexity, particularly in biologics and user-oriented drug
products, V-OVS® next represents the latest evolution of
Vetter's syringe closure technology. The system incorporates multiple design
enhancements intended to improve safety, usability, and compatibility across a
range of syringe formats, helping to establish a new standard for Luer Lock
syringe closure systems.
"We are honored that V-OVS®
next has been recognized with a Red Dot Award," said Dr. Claus
Feussner, Senior Vice President Development Service at Vetter. "This
achievement reflects our commitment to combining technical innovation with
meaningful user insights. Throughout development, we focused on creating a
closure system that enhances functionality and patient safety, while delivering
a more intuitive handling experience. Awards like this confirm that innovative
pharmaceutical packaging must address both technical requirements and human
factors to deliver meaningful value."
One of the system's key
features is a robust locking mechanism designed to provide a secure connection
between the syringe and the closure part, helping to reduce the risk of
unintended rotation. V-OVS® next also incorporates a
tamper-evident seal that irreversibly breaks upon first opening, offering an
immediate visual indication of product status while supporting safety, product
integrity, and user confidence.
In addition to its technical
advancements, the closure system was specifically engineered with user-centric
design principles. Ergonomic gripping elements help users intuitively identify
handling points, while integrated visual opening indicators contribute to a
straightforward opening process. The overall design combines functionality with
a premium appearance, enabling pharma and biotech companies to further
differentiate their therapies in an increasingly competitive marketplace.
Find the Vetter press kit and
more background information here. About
Vetter
Vetter is a leading
Contract Development and Manufacturing Organization (CDMO) with headquarters in
Ravensburg, Germany, and production facilities in Germany, Austria, and the US.
As a global player, the independent pharmaceutical service provider is also present
in the Asia-Pacific markets of Japan, China, South Korea and Singapore with
sales locations. Around the world renowned pharma and biotech companies benefit
from decades of experience, high quality, modern technologies, reliability, and
commitment of its 7,400 employees. In close collaboration with its customers,
the Vetter team helps enable the supply to patients all over the world with
medicines, many of which are vital. The CDMO provides support from drug product
development through clinical and commercial filling to a wide range of assembly
and packaging services for vials, syringes, and cartridges. With innovative
approaches, Vetter develops prefilled drug-delivery systems together with its
customers to continuously improve patient safety, comfort, and compliance.
Vetter takes responsibility for sustainable practices and operates as a
socially and ethically responsible corporate citizen. The CDMO is a member of
the UN Global Compact and Science Based Target initiative (SBTi) and received
platinum status in the renowned EcoVadis ranking. Multiple awards such as the
CDMO Leadership Awards, Frost & Sullivan Customer Value Leadership Award
and the recognition of Best Managed Company emphasize Vetter’s commitment to
sustainable business. Founded in Ravensburg in 1950, the company remains
family-owned to this day. For more information, visit www.vetter-pharma.com and
follow Vetter on LinkedIn.
Contact
Vetter
Pharma International GmbH Markus
Kirchner Corporate
Spokesperson / Media Relations Eywiesenstrasse
5 88212
Ravensburg Germany
Phone:
+49 (0)751-3700-3729 Email:
PRnews@vetter-pharma.com
© Vetter Pharma International GmbH: V-OVS® next
